Apr 01 NEW CONTENTS in the section: Rapid Molecular Microbiology
sepsis-one its contents are updated and expanded to offer all professionals in the Piensa en Sepsis community the latest advances in prevention, diagnosis, stratification and clinical management of patients with sepsis.
La bioMériux company joins the efforts against Sepsis with its participation in this specialized portal to which it contributes with its extensive experience in the Rapid Molecular Microbiological Diagnosis, in which he has been working to offer quick solutions in this clinical situation where TIME IS LIFE.
Thanks to bioMeriéux, a multitude of new contents have been incorporated in the field of microbiological diagnosis, structured by areas such as rapid syndromic diagnosis (RSD), and the latest advances in platforms for the identification of microorganisms.
In this section, the importance of the elderly group has been taken into account due to their vulnerability to sepsis.
We are sure that this is the beginning of a fruitful collaboration that will provide professionals with an updated vision of the resources and solutions in the field of rapid molecular microbiological diagnosis, which we have in this fight against time in favor of our patients with Sepsis.
We want to thank bioMerieux your support to make this progress possible.